
==== Front
Nano Converg
Nano Converg
Nano Convergence
2196-5404
Springer Nature Singapore Singapore

39292368
444
10.1186/s40580-024-00444-3
Correction
Correction to: PFP@PLGA/Cu12Sb4S13‑mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT‑CO1 signaling pathway
Dong Tianxiu 1
Jiang Jian 1
Zhang Hao 12
Liu Hongyuan 1
Zou Xiaomeng 1
Niu Jiamei 1
Mao Yingxuan 1
Zhu Mingwei 1
Chen Xi 1
Li Zizhuo 1
Chen Yaodong 3
Shi Chunying 4
Yang Xiuhua 1
1 https://ror.org/05vy2sc54 grid.412596.d 0000 0004 1797 9737 Department of Abdominal Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001 China
2 https://ror.org/03qrkhd32 grid.413985.2 0000 0004 1757 7172 Department of Medical Imaging, Heilongjiang Provincial Hospital, Harbin, 150001 China
3 https://ror.org/02vzqaq35 grid.452461.0 0000 0004 1762 8478 Department of Ultrasonic Imaging, First Hospital of Shanxi Medical University, Taiyuan, 030001 China
4 https://ror.org/05vy2sc54 grid.412596.d 0000 0004 1797 9737 Department of Radiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001 China
18 9 2024
18 9 2024
12 2024
11 37© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
issue-copyright-statement© Korea Nanotechnology Research Society (KoNTRS) 2024
==== Body
pmc Correction to: Nano Convergence (2021) 8:29

10.1186/s40580-021-00279-2

Following publication of the original article [1], the author identified the errors in the Figures, Supplementary Material and Availability of data and materials. The corrected Figs. 7A, 9A, B and Fig. S3 presented with this correction.

Fig. 7 Hyperthermia inhibits HCC migration and invasion in vitro and in vivo. A Representative images of migration assays for HCC cells in diferent groups. B Representative images of invasion assays for HCC cells. C E-cadherin, N-cadherin, Vimentin and ZEB2 expression evaluated by western blotting in HCC cells. D Holistic view and H&E staining of excised lungs from a mouse model of metastasis. Representative images of lung tissues were shown in the left panel. Arrows indicate the location of metastatic lung foci. Corresponding H&E staining of metastatic lung foci were shown in the right panel. The scale bar=100 μm. E Incidence of metastatic lung nodules of each group. **p<0.01

Fig. 9 Mechanistic analysis of PTT with PPCu. A H&E, ki67, MT-CO1 and TUNEL staining of tumor regions in every group. Scale bar=100 μm. B H&E staining of heart, liver, spleen, lung and kidney collected from diferent groups of mice at the 14th day after diferent treatments

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Data availability

All datasets and materials used during the current study are available from the corresponding author on reasonable request.

The online version of the original article can be found at 10.1186/s40580-021-00279-2.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Tianxiu Dong and Jian Jiang contributed equally to this work.
==== Refs
Reference

1. Dong, T., Jiang, J., Zhang, H. et al. PFP@PLGA/Cu12Sb4S13-mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathway. Nano Convergence 8, 29 (2021).
